Clinical Trial Update: Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for buparlisib in melanoma patients with brain metastases (BUMPER). The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• Buparlisib (buparlisib)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Malignant Melanoma, Metastases | Phase 2 | Status: UNKNOWN